Invention Grant
- Patent Title: Triazolopyridine compounds as PIM kinase inhibitors
- Patent Title (中): 三唑并吡啶化合物作为PIM激酶抑制剂
-
Application No.: US13059881Application Date: 2009-08-18
-
Publication No.: US08557809B2Publication Date: 2013-10-15
- Inventor: Shelley Allen , Robert Kirk DeLisle , Julie Marie Greschuk , Erik James Hicken , Joseph P. Lyssikatos , Fredrik P. Marmsater , Mark C. Munson , John E. Robinson , Qian Zhao
- Applicant: Shelley Allen , Robert Kirk DeLisle , Julie Marie Greschuk , Erik James Hicken , Joseph P. Lyssikatos , Fredrik P. Marmsater , Mark C. Munson , John E. Robinson , Qian Zhao
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris & Padys PLLP
- Agent John R. Moore, Esq.; Sarah S. Mastous
- International Application: PCT/US2009/054198 WO 20090818
- International Announcement: WO2010/022081 WO 20100225
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/496 ; A61K31/4709 ; C07D471/04 ; A61P35/02 ; A61P29/00
Abstract:
Compounds of Formula (I): I in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
Public/Granted literature
- US20110144100A1 TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS Public/Granted day:2011-06-16
Information query
IPC分类:
